Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
July 31, 2026 0.2478M
April 30, 2026 -0.2044M
January 31, 2026 -9.589M
October 31, 2025 10.15M
July 31, 2025 -0.27M
April 30, 2025 -0.3062M
January 31, 2025 7.292M
October 31, 2024 1.520M
July 31, 2024 1.968M
April 30, 2024 0.8279M
January 31, 2024 0.4514M
October 31, 2023 -0.2234M
July 31, 2023 -0.3035M
April 30, 2023 -0.2804M
January 31, 2023 -0.2096M
October 31, 2022 0.1497M
July 31, 2022 -0.1181M
April 30, 2022 2.417M
January 31, 2022 -0.0395M
October 31, 2021 0.069M
July 31, 2021 -0.1708M
April 30, 2021 23.10M
January 31, 2021 0.3757M
October 31, 2020 8.380M
July 31, 2020 2.612M
Date Value
April 30, 2020 0.4341M
January 31, 2020 -0.0348M
October 31, 2019 -0.1905M
July 31, 2019 -0.082M
April 30, 2019 -0.045M
January 31, 2019 -0.1859M
October 31, 2018 6.583M
July 31, 2018 0.6683M
April 30, 2018 3.438M
January 31, 2018 0.0685M
October 31, 2017 4.120M
July 31, 2017 0.0564M
April 30, 2017 0.004M
January 31, 2017
June 30, 2016
March 31, 2016
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00
December 31, 2013 0.0695M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Repligen Corp. -6.20M
Bio-Techne Corp. -33.21M
BioLife Solutions, Inc. -3.594M
Maravai Lifesciences Holdings, Inc. -98.98M
MaxCyte, Inc. -1.42M